|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Non-controlled/non-affiliate company investments at fair value (amortized cost of $399,555 and $385,232, respectively) | ||||||||||||||
| Cash | ||||||||||||||
| Cash equivalents | ||||||||||||||
| Foreign currencies (cost of $217 and $132, respectively) | ||||||||||||||
| Cash collateral for forward currency contracts | ||||||||||||||
| Interest receivable | ||||||||||||||
| Receivable for investments | ||||||||||||||
| Deferred offering costs | ||||||||||||||
| Net unrealized appreciation on forward currency contracts | ||||||||||||||
| Other assets | ||||||||||||||
| Total Assets | ||||||||||||||
| Liabilities | ||||||||||||||
| Interest payable | ||||||||||||||
| Distributions payable | ||||||||||||||
| Management and incentive fees payable | ||||||||||||||
| Management and income incentive fees payable | ||||||||||||||
| Payable for investments purchased | ||||||||||||||
| Capital calls received in advance | ||||||||||||||
| Accrued trustee fees | ||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||
| Unrealized depreciation on forward currency contracts | ||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||
| Total Liabilities | ||||||||||||||
| Net Assets | ||||||||||||||
| Preferred stock, par value $0.001 per share, 1,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and September 30, 2025 | ||||||||||||||
| Common stock, par value $0.001 per share, 200,000,000 shares authorized, 26,772,467.472 shares issued and outstanding as of June 30, 2026 and September 30, 2025 | ||||||||||||||
| Paid in capital in excess of par | ||||||||||||||
| Distributable earnings (losses) | ||||||||||||||
| Total Net Assets | ||||||||||||||
| Total Liabilities and Total Net Assets | ||||||||||||||
| Number of common shares outstanding (in shares) | ||||||||||||||
| Net asset value per common share (in dollars per share) | ||||||||||||||
Loading...
